This article provides educational context on transdermal delivery technology, bioavailability considerations, and evaluation criteria consumers may find useful when researching this emerging supplement category
But if we stay on our current path, these advances will be subsumed by unnecessary costs, new layers of administration, and invented complexityjust like the past two decades of efficiencies were swallowed up
[17] The GIP receptor component further augments insulin secretion and may improve fat metabolism
In addition, regulatory bodies are adapting to the evolving landscape, which may facilitate faster approvals for innovative therapies
avoid exaggerating benefits
Diabetes 59: 1765-1770, 2010